Usages in wwPDB of concept: c_0127
nUsages: 116; SSE string: EEHEEEEEHEEE
1a4k:B     (GLY8) to   (SER112)  DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE  |   IMMUNOGLOBULIN, ANTIBODY, CATALYTIC ANTIBODY, DIELS ALDER, GERMLINE 
4gxu:N     (LEU4) to   (VAL106)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gxu:P     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gxu:R     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gxu:T     (PRO8) to   (THR105)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gxu:X     (LEU4) to   (THR105)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gxv:M     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1  |   IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
1nl0:L     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY, 10C12  |   IMMUNE SYSTEM, ANTIBODY, GLA DOMAIN 
4hj0:D     (PRO8) to   (VAL109)  CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION  |   GLUCAGON RECEPTOR SUB-FAMILY RECOGNITION FOLD, IMMUNE SYSTEM 
1bjm:A     (PRO8) to   (VAL109)  LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4  |   BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN 
1bjm:B     (PRO8) to   (VAL109)  LOC NAKS, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN NAKSO4  |   BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN 
3t0v:A     (PRO8) to   (VAL106)  UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL  |   IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN 
3t0x:B     (PRO8) to   (VAL106)  FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED  |   IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN 
3ghe:L     (ALA8) to   (VAL106)  CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 537-10D IN COMPLEX WITH V3 PEPTIDE MN  |   HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE PROTEIN, IMMUNE SYSTEM 
3tje:L     (SER9) to   (VAL109)  CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09  |   AGONISTIC ANTIBODY, FAB FRAGMENT, ANTIBODY-RECEPTOR COMPLEX, TUMOR NECROSIS FACTOR RECEPTOR, CYSTEINE-RICH DOMAIN, FAS, IMMUNE SYSTEM 
2rhe:A     (PRO8) to   (GLY111)  STRUCTURE OF A NOVEL BENCE-JONES PROTEIN (RHE) FRAGMENT AT 1.6 ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
4yjz:L     (LEU8) to   (LEU110)  HUMAN ANTIBODY H2526 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006  |   INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3u36:L     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF PG9 FAB  |   IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM 
3u36:B     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF PG9 FAB  |   IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM 
3u36:D     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF PG9 FAB  |   IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM 
3u36:F     (SER9) to   (THR105)  CRYSTAL STRUCTURE OF PG9 FAB  |   IMMUNOGLOBULIN, GP120 BINDING, IMMUNE SYSTEM 
3hae:N     (SER9) to   (VAL108)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4k3d:L     (SER8) to   (VAL106)  CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3  |   IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4k3d:M     (SER8) to   (GLY107)  CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3  |   IMMUNOGLOBULIN, CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4k3e:L     (SER8) to   (GLY107)  CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3  |   IMMUNOGLOBULIN; CYSTINE KNOT, IMMUNE RECOGNITION, IMMUNE SYSTEM 
3ujj:L     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE  |   IG DOMAINS, ANTIBODY FAB, ANTIGEN BINDING, THE THIRD VARIABLE REGION OF HIV-1 GP120, IMMUNE SYSTEM 
2fb4:L     (PRO8) to   (VAL107)  DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)  |   IMMUNOGLOBULIN 
1rzf:L     (PRO9) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
3iyw:L     (SER9) to   (VAL109)  WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)  |   VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS 
3iyw:M     (SER9) to   (VAL109)  WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)  |   VIRUS-ANTIBODY COMPLEX, NEUTRALIZING FAB FRAGMENT, FLAVIVIRUS, WEST NILE VIRUS, ENVELOPE PROTEIN, ICOSAHEDRAL VIRUS, VIRUS 
4m6m:L     (SER9) to   (VAL110)  CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
5acl:A     (PRO8) to   (VAL109)  MCG IMMUNOGLOBULIN VARIABLE DOMAIN WITH SULFASALAZINE  |   IMMUNE SYSTEM, MCG, IMMUNOGLOBULIN VARIABLE DOMAIN,  METHYLENE BLUE 
5acm:A     (PRO8) to   (VAL109)  MCG IMMUNOGLOBULIN VARIABLE DOMAIN WITH METHYLENE BLUE  |   IMMUNE SYSTEM, MCG, IMMUNOGLOBULIN VARIABLE DOMAIN, METHYLENE BLUE 
5alb:L     (PRO9) to   (VAL106)  TICAGRELOR ANTIDOTE CANDIDATE MEDI2452 IN COMPLEX WITH TICAGRELOR  |   IMMUNE SYSTEM, ANTIBODY FRAGMENT, ANTIDOTE, DRUG 
5awn:L     (SER9) to   (SER105)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB  |   HIV-1, ENV, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
2jb6:L     (ALA8) to   (VAL110)  FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2  |   CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM 
2xwt:B     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY  |   SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX, GPCR, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR-AUTOANTIBODY COMPLEX 
5c0s:L     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261  |   HEMAGGLUTININ, IMMUNOGEN, TRIMER, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4nzt:L     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB  |   LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
5cba:B     (ALA8) to   (VAL106)  3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13  |   ANTI-CXCL13, CXCL13, SCFV, IMMUNE SYSTEM 
2ykl:L    (SER10) to   (ILE106)  STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE  |   IMMUNE SYSTEM, MONOCLONAL ANTIBODIES, ANTI-SMOKING VACCINE 
5cck:L     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB  |   HIV-1, ENV, BNAB, ANTIBODY, IMMUNE SYSTEM 
4ocr:L     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY  |   FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM 
4od2:A     (PRO7) to   (THR105)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5  |   IGG, FAB FRAGMENT,CRD,TNFSF, APOPTOSIS-IMMUNE SYSTEM COMPLEX 
3kdm:A     (ALA8) to   (THR113)  CRYSTAL STRUCTURE OF HUMAN ANTI-STEROID FAB 5F2 IN COMPLEX WITH TESTOSTERONE  |   IMMUNE SYSTEM, ANTIBODY, IMMUNOGLOBULIN FAB FRAGMENT, ANTI-STEROID 
4ot1:L     (PRO8) to   (VAL108)  STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1  |   IMMUNOGLOBULIN, PH DOMAIN, ANTIBODY-ANTIGEN RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1mcd:A     (PRO8) to   (VAL109)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
5dur:L     (SER9) to   (GLY113)  INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4  |   INFLUENZA VIRUS, ANTIBODY, COMPLEX, NEUTRALIZE, IMMUNE SYSTEM 
4q2z:L     (SER9) to   (VAL106)  FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE356, FROM A NON-HUMAN PRIMATE  |   FAB FRAGMENT, HIV VIRAL ENVELOPE GLYCOPROTEIN NEUTRALIZATION, IMMUNE SYSTEM 
3lrg:A     (SER9) to   (ALA112)  STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN  |   HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3lrg:B     (SER9) to   (VAL109)  STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN  |   HUNTINGTON'S DISEASE, HUNTINGTIN, VARIABLE LIGHT CHAIN DOMAIN, INTRABODY, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2a9n:L     (SER9) to   (VAL147)  A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX  |   IMMUNOGLOBULIN, FLUORESCEIN, SCFV, IMMUNE SYSTEM 
2a9n:M     (SER9) to   (VAL147)  A MUTATION DESIGNED TO ALTER CRYSTAL PACKING PERMITS STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV COMPLEX  |   IMMUNOGLOBULIN, FLUORESCEIN, SCFV, IMMUNE SYSTEM 
3mlw:L     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3mlw:M     (PRO8) to   (THR105)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3mme:L     (ALA8) to   (VAL105)  STRUCTURE AND FUNCTIONAL DISSECTION OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1  |   NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM 
3bjl:A     (PRO8) to   (VAL109)  LOC, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN AMMONIUM SULFATE  |   BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN 
5f6h:L     (PRO8) to   (GLY111)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
5f6h:N     (PRO8) to   (GLY111)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
5f6j:A     (PRO8) to   (VAL109)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE  |   FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX 
5f6j:F     (PRO8) to   (VAL109)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE IN COMPLEX WITH HIV-1 GP120 CORE  |   FAB FRAGMENT, HIV-1, ANTIBODY, VIRAL PROTEIN-IMMUE SYSTEM COMPLEX 
4buh:A   (PRO149) to   (VAL250)  HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV  |   IMMUNE SYSTEM, ANTIBODY, ALLERGEN 
3n9g:L     (SER9) to   (VAL109)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354  |   FAB FRAGMENT, HUMAN NEUTRALIZING ANTIBODY, MAB CR4354, IMMUNE SYSTEM, ANTI-WEST NILE VIRUS 
4rfe:L     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB  |   HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM 
4rfe:D     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB  |   HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM 
4rfe:F     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB  |   HIV-1 GP120 SPECIFIC ANTIBODY, CD4I ANTIBODY, ADCC, HIV-1 ENV, ANTI- HIV-1 ENV ANTIBODY JR4, IMMUNE SYSTEM 
4rfn:L     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48  |   HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4rfn:C     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48  |   HIV-1 GP120, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3nps:C     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4  |   HYDROLASE, ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME-INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE, HYDROLASE - IMMUNE SYSTEM COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3d69:L     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12  |   ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM 
4tsb:L     (SER9) to   (GLY107)  STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX  |   ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX 
5grj:L     (LEU4) to   (VAL109)  CRYSTAL STRUCTURE OF HUMAN PD-L1 WITH MONOCLONAL ANTIBODY AVELUMAB  |   PD-L1, AVELUMAB, MONOCLONAL ANTIBODY, TUMOR IMMUNOTHEPAPY, IMMUNE SYSTEM 
4ut7:L     (VAL8) to   (VAL106)  CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11  |   IMMUNE SYSTEM, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, SCFV FRAGMENT 
4utb:L     (VAL8) to   (VAL106)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT 
4utb:M     (VAL8) to   (VAL106)  CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY , IMMUNE SYSTEM, FAB FRAGMENT 
4evn:B     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:D     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:F     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:H     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:J     (PRO8) to   (GLY112)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:L     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:N     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
4evn:P     (PRO8) to   (VAL110)  CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)  |   ANTIBODY, IMMUNE SYSTEM, INFLUENZA HA 
5j74:A   (SER151) to   (VAL251)  FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P  |   FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM 
5j74:B   (SER151) to   (VAL251)  FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P  |   FLUOROGEN ACTIVATING PROTEIN DRUG DISCOVERY BIOSENSOR PROTEIN TRAFFICKING, PROTEIN BINDING, IMMUNE SYSTEM 
5j75:A   (SER151) to   (VAL251)  FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342  |   FLUOROGEN ACTIVATING PROTEIN, DRUG DISCOVERY, BIOSENSOR, PROTEIN TRAFFICKING, IMMUNE SYSTEM 
5j75:B   (SER151) to   (VAL251)  FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342  |   FLUOROGEN ACTIVATING PROTEIN, DRUG DISCOVERY, BIOSENSOR, PROTEIN TRAFFICKING, IMMUNE SYSTEM 
4fqh:L     (ALA9) to   (LEU106)  CRYSTAL STRUCTURE OF FAB CR9114  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM 
4fqh:B     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF FAB CR9114  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPE, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, INFLUENZA VIRUS, INFLUENZA VACCINES, MEMBRANE FUSION, IMMUNE SYSTEM 
4fqi:L     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H5N1 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqj:L     (LEU4) to   (VAL106)  INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX  |   MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqk:F     (LEU4) to   (VAL106)  INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX  |   ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX 
4fqk:L     (LEU4) to   (VAL106)  INFLUENZA B/BRISBANE/60/2008 HEMAGGLUTININ FAB CR8059 COMPLEX  |   ANTIBODY, FAB FRAGMENT, MONOCLONAL, IMMUNOGLOBULIN, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX 
4fqv:L     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqv:M     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqv:N     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqy:L     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5lcv:L     (VAL8) to   (VAL106)  STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3g04:A     (PRO8) to   (VAL106)  CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY  |   TSH RECEPTOR, GPCR, THYROID, GRAVES' DISEASE, AUTOIMMUNITY, RECEPTOR- AUTOANTIBODY COMPLEX, IMMUNE SYSTEM 
4y5v:B     (ALA8) to   (LEU110)  DIABODY 305 COMPLEX WITH EPOR  |   DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
4y5v:H     (ALA8) to   (VAL109)  DIABODY 305 COMPLEX WITH EPOR  |   DIABODY COMPLEX, RECEPTOR, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX 
4y5x:K     (PRO8) to   (ALA111)  DIABODY 305 COMPLEX WITH EPOR  |   DIABODY COMPLEX, RECEPTOR 
3h42:L     (SER9) to   (VAL110)  CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY  |   HYDROLASE, PROTEIN FAB COMPLEX, AUTOCATALYTIC CLEAVAGE, CHOLESTEROL METABOLISM, DISEASE MUTATION, DISULFIDE BOND, GLYCOPROTEIN, LIPID METABOLISM, PHOSPHOPROTEIN, PROTEASE, SECRETED, SERINE PROTEASE, STEROID METABOLISM, ZYMOGEN, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3ux9:B    (SER11) to   (VAL111)  STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS  |   FIVE HELICES, LONG LOOP CONNECTING HELIX, HYDROPHOBIC INTERACTIONS, CYTOKINE-IMMUNE SYSTEM COMPLEX 
3ux9:D    (SER11) to   (VAL111)  STRUCTURAL INSIGHTS INTO A HUMAN ANTI-IFN ANTIBODY EXERTING THERAPEUTIC POTENTIAL FOR SYSTEMIC LUPUS ERYTHEMATOSUS  |   FIVE HELICES, LONG LOOP CONNECTING HELIX, HYDROPHOBIC INTERACTIONS, CYTOKINE-IMMUNE SYSTEM COMPLEX 
2yk1:L     (PRO9) to   (GLY107)  STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE  |   IMMUNE SYSTEM, MONOCLONAL ANTIBODIES, ANTI-SMOKING VACCINE 
5cgy:L     (PRO8) to   (VAL110)  FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21  |   ANTIBODY, FAB, IMMUNE SYSTEM 
5cjs:E     (ALA9) to   (VAL106)  CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114  |   HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4py8:I    (GLY10) to   (SER121)  CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ  |   HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, MEMBRANE FUSION, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2a9m:L     (SER9) to   (VAL147)  STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM  |   IMMUNOGLOBULINS, FLUORESCEIN, IMMUNE SYSTEM 
3mlx:M     (SER9) to   (VAL106)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
4tsc:L     (PRO8) to   (GLY107)  STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX  |   ANTIBODY, AFFINITY MATURATION, IMMUNE SYSTEM-HYDROLASE COMPLEX 
4ttd:D     (SER9) to   (VAL106)  STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX  |   IMMUNE SYSTEM, AFFINITY MATURATION 
4d9l:L     (SER9) to   (VAL106)  FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
4d9l:M     (SER9) to   (VAL106)  FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM 
4d9l:O     (SER9) to   (VAL106)  FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697  |   IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM